Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYSLTR1 | Q9Y271 | 8/20 | 0.59 |
| ▸ | CYSLTR2 | Q9NS75 | 7/20 | 0.58 |
| ▸ | ALOX5 | P09917 | 10/20 | 0.56 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.54 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.53 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.53 |
| ▸ | GPBAR1 | Q8TDU6 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7234584 | 0.83 | CYSLTR1 (0.60) | CYSLTR1CYSLTR2ALOX5HDAC6FFAR1 | |
| SCHEMBL8965425 | 0.79 | CYSLTR1 (0.64) | CYSLTR1CYSLTR2ALOX5HDAC6FFAR1 | |
| SCHEMBL9018918 | 0.78 | PDE10A (0.57) | CYSLTR1CYSLTR2ALOX5HDAC6GPBAR1 | |
| SCHEMBL10438460 | 0.77 | CYSLTR1 (0.65) | CYSLTR1CYSLTR2ALOX5HDAC6GPBAR1 | |
| SCHEMBL10438395 | 0.77 | CYSLTR1 (0.65) | CYSLTR1CYSLTR2ALOX5HDAC6GPBAR1 | |
| SCHEMBL10438455 | 0.77 | CYSLTR1 (0.65) | CYSLTR1CYSLTR2ALOX5HDAC6GPBAR1 | |
| SCHEMBL2108349 | 0.77 | ALOX5 (0.61) | CYSLTR1CYSLTR2ALOX5HDAC6FFAR1 | |
| SCHEMBL8503501 | 0.76 | CYSLTR1 (0.66) | CYSLTR1CYSLTR2ALOX5HDAC6FFAR1 | |
| SCHEMBL3076102 | 0.75 | CYSLTR1 (1.00) | CYSLTR1CYSLTR2ALOX5FFAR1AKR1B1 | |
| SCHEMBL8317460 | 0.75 | CYSLTR1 (0.74) | CYSLTR1CYSLTR2ALOX5FFAR1AKR1B1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5512581-A | ANTIINFLAMMATORY AGENT | ABBOTT LABORATORIES (US) | 1996-04-30 | — | — | US | disclosed |